difference. i started to feel better within 24 hours of starting them and i genuinely think if i hadn t taken them i would have ended up being hospitalised. them i would have ended up being hospitalised- hospitalised. amy was given the tablets due hospitalised. amy was given the tablets due to hospitalised. amy was given the tablets due to complex - hospitalised. amy was given the tablets due to complex health . hospitalised. amy was given the - tablets due to complex health issues rather than through the trial but it is hoped the study running since the 8th of december will continue to see people sign up. to take part you need to be over 50 or 18 49 with an underlying health condition. you need a positive test and start within five days of symptoms. the trial requires no face to face contact. the tablets are delivered and you will receive a phone call from a gp about how they work. the dru: is from a gp about how they work. ii;e: drug is absorbed by from a gp about how they work.
infected the drug is absorbed by covid infected cells and blocks how the virus infected cells and blocks how the virus replicates in the body. they should virus replicates in the body. they should make it harder for the covid virus should make it harder for the covid virus to should make it harder for the covid virus to reproduce and reduce the risk of virus to reproduce and reduce the risk of developing serious disease. the study risk of developing serious disease. the study is being delivered here by public health wales, health and care research wales and cardiff university, with a focus on making sure it is open to everyone. the boston clinical sure it is open to everyone. iie: boston clinical trials were sure it is open to everyone. ti2 boston clinical trials were done in very specialised centres, and it is a very particular type of person that goes into them, so we are really, really keen on making sure people live in rural areas have a chance to get involved and to t
hospital. and the other reason is the way that this drug works. the drug the drug works by introducing errors into the way the virus replicates and the concerns is that it might introduce errors that help the virus. you don t want to use it more widely than you need to. good point. what is your emergency here we don t have a ton of time, so i m curious, though, to people who say, you know, there are already anti-vax advocates who say, listen, we have these anti-viral drugs now to treat covid so it doesn t matter if you get the shot or not. what s your message to those folks? well, it s never going to replace it. like i said, prevention is always going to be better than cure. do you want to be one of the 50% who do end up being in the hospital? and even if you don t end up in the hospital, there s also the risk of having long covid which we know in a percentage of people who recover you might have persistent symptoms for a while. of course, you know, like i said, i think that we
is this the vaccine this could be used in conjunction with the vaccine and it s not an alternative to vaccination and we need to get more people vaccinated who have breakthrough infections and still develop symptomatic disease that are at risk and there are people who choose not to get vaccinated for whom this can be effective and it can be used like tamiflu, and some people still develop symptomatic disease and tamiflu provides an alternative to help the progression of symptoms in individuals and this could be used the same way. the bottom line is the mechanisms by which this virus replicates are well understood. this isn t a virus that replicates through complicated mechanisms that will be hard to drug. there are multiple drugs in development including one on the board of pfizer and another one by roche. it could be effective and it could be a game changer in so far that it helps people that have breakthrough infections and
um, i think getting an oral pill that can inhibit viral replication, that can inhibit this virus is going to be a real game-changer. this drug works by mechanisms that are well understood as other drugs on the market that work by similar mechanisms. basically, it works by in inducing errors in how this virus replicates. so as the virus replicates, it makes mistakes in replication and it basically kills the virus. so these are targets. this virus is well understood and the mechanisms by which it replicates are well understood so i think we will get an oral drug that can inhibit inhibit viral replication and be taken early in the course of disease to either prevent progression or be used as a prophylaxis. so, let s be just drill down that a little bit. this could be something for i mean, is this something that people who don t want to be vaccinated would would gravitate to? i mean, is you know, if the argument is i mean, i guess, obviously, for those who don t want to be